Ingham Institute

What Ingham Institute does

Ingham Institute for Applied Medical Research is a charitable not-for-profit translational medical research institute founded in 2008 and headquartered at Liverpool, NSW, Australia, with a second site at Campbelltown (Macarthur, opened December 2025) and a third site in Bankstown in planning. The institute operates as the constitutionally-embedded, exclusive Medical Research Institute for South Western Sydney, affiliated with over 350 researcher affiliates across 40 research groups (with more than half being practising clinicians across the SWSLHD hospital network), 90+ PhD students, and formal academic affiliations with UNSW Sydney and Western Sydney University. Its research spans cancer, cardiovascular disease, neurology and stroke, obstetrics and women's health, diabetes, childhood wellbeing, brain injury, gastroenterology and liver disease, and integrated oral health, supported by cross-cutting platforms including a Correlative Microscopy Facility (housing one of Australia's most powerful Field Emission Scanning Electron Microscopes), an MRI-Linac program, the Perich Centre for Robotics & Health Technology, the Australian Centre for Cancer Equity, and the CATALYST AI-in-Health Incubator with proprietary tools such as PRISM (Patient Record Intelligence and Summarisation Module), voice-text transcription and an AI-powered health coach. The institute runs 200+ active clinical trials and has conducted over 500 cumulatively.

The institute is funded through a hybrid of philanthropy (founding gift from Bob Ingham AO and Lady Mary Fairfax AC OBE; subsequent major gifts including Lang Walker AO's funding of the Macarthur building), structured giving programs (donations, wills and bequests, workplace giving, corporate partnerships, in-memory giving), and clinical trial revenue from industry partners and government research grants. It does not sell products or services commercially; pricing consists of tax-deductible donation tiers (A$375, A$1,500, A$3,750, A$7,500 or custom amounts). Distribution occurs through co-location with SWSLHD hospitals, the clinical trials platform, research publication and international knowledge transfer (including WHO-aligned viral hepatitis elimination work), and donation/fundraising channels. Its primary customer base is the South Western Sydney community of 1.2 million people (forecast to grow 33% by 2031) — one of Australia's most culturally diverse regions, with ~50% speaking a language other than English at home and half the population in the lowest socioeconomic quintile — alongside secondary stakeholders in healthcare systems, indigenous communities, donor/philanthropy segments and clinical trial sponsors.

Name

Ingham Institute

Legal name

Ingham Institute for Applied Medical Research

Website

https://inghaminstitute.org.au

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Ingham Institute is a charitable translational medical research institute, founded 2008, that serves as the exclusive Medical Research Institute for South Western Sydney's 1.2 million residents via 350+ affiliated clinicians across 40 research groups, funded primarily by philanthropy and clinical trial revenue.

Ownership category

akta.pro rank

Product category

Translational Medical Research

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Health Informatics & Digital Health Programs (EDAHAGAJ), Global Health Institutes & Programs (EDAHAGAM)

Keywords

• Translational medical research
• Clinical trials services
• Cancer research programs
• Cardiovascular research
• Health technology innovation

Headquarters

HQ city

Liverpool

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Donations and Fundraising: As a charitable not-for-profit organization, Ingham Institute relies on public donations and fundraising to support researchers' vital work. Multiple giving mechanisms including one-time donations, appeals, in-memory giving, and workplace giving programs.
2. Philanthropy and Corporate Partnerships: Structured giving programs for individuals and corporations seeking to support medical research with potential for naming rights, recognition, and impact alignment.
3. Wills and Bequests: Legacy giving programs allowing donors to include Ingham Institute in their estate planning.
4. Clinical Trials Revenue: Revenue generated through conducting clinical trials for industry partners, pharmaceutical companies, and research grants.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Ingham Institute is a translational medical research institute that conducts laboratory-based discovery science, disease-focused clinical research and clinical trials across cancer, cardiovascular, neurology and stroke, obstetrics and women's health, childhood wellbeing, diabetes and other priority areas. It delivers research outputs through dedicated centres and co-located infrastructure at major teaching hospitals in South Western Sydney, with a mission of translating laboratory discoveries into direct patient and community health benefits and addressing health inequity for a culturally diverse population of 1.2 million people.

Product overview

Ingham Institute for Applied Medical Research is a translational medical research institute operating as a single platform with multiple specialized research centers and cross-cutting platforms. The core offering consists of disease-focused Research Centers (Cancer, Cardiovascular, Neurology/Stroke, Obstetrics/Women's Health, Diabetes, Childhood Wellbeing) complemented by the Perich Centre for Robotics & Health Technology and Australian Centre for Cancer Equity (AcCE) as flagship programs. Cross-cutting platforms (Allied Health, Clinical Trials, Correlative Microscopy, Nursing/Midwifery) and Clinical Academic Units (Brain Injury, Gastroenterology/Liver, Oral Health, Women's Health) provide shared infrastructure and enable research across disease areas. The institute recently launched the CATALYST Hub for AI-in-Health innovation and the Perich Centre for Robotics & Health Technology as dedicated 1,300 sqm facilities for health technology advancement. With sites co-located at Liverpool Hospital, Campbelltown Hospital, and future Bankstown location, the institute operates under a network model enabling rapid translation of research into clinical practice.

Differentiator

Problem solved

Functional benefit

Brands

• Australian Centre for Cancer Equity (AcCE): A national partnership addressing disparity in cancer outcomes, founded with SWSLHD and NSW Cancer Institute, targeting equity for Indigenous communities, rural populations, and culturally diverse groups.
• Perich Centre for Robotics & Health Technology
• Australian Centre for Integration of Oral Health (ACIOH)

Products and services

• Perich Centre for Robotics & Health Technology A 1,300 sqm dedicated facility delivering healthcare automation research including the AI-in-Health Incubator (CATALYST Hub), surgical robotics training, rehabilitation robotics and assistive technologies — for clinical-research teams, hospital partners and industry sponsors translating robotics and health-technology innovation into clinical practice.
• Australian Centre for Cancer Equity (AcCE) National research centre addressing disparity in cancer outcomes through population health, accessible health systems, genomics, AI and digital innovation, and equity for Indigenous communities and culturally diverse groups — for cancer patients, health-system policy makers and equity-focused research collaborators.
• CATALYST Hub (AI in Health Incubator) In-house sovereign clinical-AI capability co-developing, testing and scaling AI solutions such as the Patient Record Intelligence and Summarisation Module (PRISM), voice-text transcription and an AI-powered personalised health coach — for clinicians, healthcare administrators and AI development partners.
• Smart Stroke Ambulance Project Technology-enabled pre-hospital stroke diagnosis system enabling paramedics to identify large vessel occlusion strokes on-board the ambulance and communicate directly with stroke teams for rapid treatment — for stroke patients, paramedics and hospital stroke teams in South Western Sydney.
• Watch Me Grow (WMG) digital tool Innovative digital platform for early identification of developmental and behavioural problems in children, supporting developmental surveillance and intervention in the first 2000 days of life — for paediatric clinicians, child and family health nurses, and families.
• Crohn's Colitis Care clinical management platform Clinical management platform for inflammatory bowel disease deployed at 19 leading IBD centres across Australia, New Zealand and internationally — for gastroenterologists, IBD patients and the Australian Centre for Integration of Oral Health network.
• Midwifery Initiated Oral Health-Dental Service (MIOH-DS) Midwife-delivered oral-health education, screening and referral model for pregnant women, adopted into policy and practice across Australia and endorsed by the World Health Organization — for pregnant women, midwives and public-health policy makers.
• Clinical Trials Platform Over 200 active clinical trials across therapeutic areas delivered in partnership with SWSLHD, ensuring diverse populations are represented in research that shapes healthcare futures — for pharmaceutical, biotechnology and medical-device industry sponsors.
• Assistive Technology Hub Specialist service providing assistive-technology development, assessment and implementation for people with acquired brain injury, including gamification of rehabilitation through video games, virtual reality and robotic therapy tools — for ABI patients, clinicians and rehabilitation teams.
• Correlative Microscopy Facility Advanced microscopy platform housing Carl Zeiss GeminiSEM 300 Field Emission Scanning Electron Microscope and Zeiss LSM 800 Super-Resolution Confocal Laser Scanning Microscope for visualising cellular structures at nanometre scale, including detection of cancer biomarkers in human tissue and high-speed live-cell imaging — for researchers across the institute and external collaborators.

Quantifiable outcome

• 33% population growth in South Western Sydney by 2031 drives urgent need for expanded research reach
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

Partnerships

Six partnerships are on record, tiered core/flagship and strategic.

• South Western Sydney Local Health District (SWSLHD)core/flagshipStrategic or Co-development PartnerFoundational partnership embedded in the Institute's Constitution. Ingham Institute is the exclusive Medical Research Institute for the region - an uncommonly rare status in NSW. The LHD provides clinical infrastructure while the institute conducts research directly informed by Clinical Service Plans, ensuring demographic-driven research focus.
• UNSW Sydneycore/flagshipStrategic or Co-development PartnerFormal affiliation with University of New South Wales. Majority of researchers hold academic posts with UNSW. Partnership enables clinician-researcher training and access to university resources for translational research.
• Western Sydney Universitycore/flagshipStrategic or Co-development PartnerFormal affiliation enabling academic appointments and research collaboration. PhD students from Western Sydney University participate in clinical trials and research programs at the institute.
• Victor Chang Cardiac Research InstitutestrategicStrategic or Co-development PartnerPartnership for Cardiovascular Research Hub led by Professor Kaz Negishi to strengthen heart research nationally. Combines expertise of Victor Chang, UNSW, and SWSLHD.
• International Medical Robotics Academy (IMRA)strategicStrategic or Co-development PartnerPartnership delivered a state-first surgical robotics training program in Liverpool, training the surgeons of the future in South Western Sydney.
• Australian Centre for Cancer Equity (AcCE)core/flagshipStrategic or Co-development PartnerFounding partnership with SWSLHD and NSW Cancer Institute in 2024. National platform targeting disparity in cancer outcomes through prevention, accessible health systems, genomics, AI, and equity for Indigenous communities.

Scale indicators12 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Telethon Kids Institute: Perth-based children's health and medical research institute with hospital co-location (Perth Children's Hospital) and university affiliations. Comparable as a multi-disciplinary translational institute with strong philanthropy linkage (Telethon).
• Baker Heart and Diabetes Institute: Melbourne-based translational research institute focused on cardiovascular and metabolic disease. Comparable translational orientation, multi-site operating model, and significant hospital partnerships.
• Centenary Institute: Sydney-based medical research institute affiliated with the Royal Prince Alfred Hospital and University of Sydney. Comparable in scale, focus on cancer/immunology/cardiovascular research, and translational model embedded in a public hospital.
• Walter and Eliza Hall Institute of Medical Research: Australia's oldest medical research institute based in Melbourne, affiliated with the Royal Melbourne Hospital and University of Melbourne. Closest large-scale Australian comparator on research depth, hospital integration, and translational pipeline.
• George Institute for Global Health: Australia-based global health research institute with major focus on health equity, chronic disease, and populations facing healthcare access barriers. Highly comparable on equity-driven translational research and globally diverse patient population framing.
• Garvan Institute of Medical Research: Sydney-based translational medical research institute affiliated with St Vincent's Hospital and UNSW. Comparable in scale (~600+ researchers), focus on genomics/cancer, and embedded hospital co-location model.
• Harry Perkins Institute of Medical Research: Perth-based medical research institute focused on cancer, diabetes, and cardiovascular disease. Comparable as an Australian translational research institute with multi-site hospital co-location and significant philanthropy-dependent funding.
• Victor Chang Cardiac Research Institute: Sydney-based independent medical research institute focused on cardiovascular disease. Already a formal strategic partner with Ingham via the Cardiovascular Research Hub, making it the closest comparable on mission, funding model, and translational research orientation.
• QIMR Berghofer Medical Research Institute: Queensland-based translational medical research institute with hospital co-location and university affiliation. Similar scale, translational focus across cancer/infectious disease/mental health, and dependence on government, philanthropy, and competitive grants.

Regional players

• Florey Institute of Neuroscience and Mental Health: Melbourne-based neuroscience and mental health research institute affiliated with the University of Melbourne and multiple hospitals. Comparable on translational neuroscience research, hospital co-location, and academic-medical integration; overlaps with Ingham's neurology and mental health programs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/InghamInstitute
• Facebookfacebook.com/InghamInstitute

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ingham Institute